AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	249,559	215,159	133,010	81,183	63,886	75,255
Market Cap Growth	61.76%	61.76%	63.84%	27.07%	-15.11%	25.87%
Enterprise Value	244,549	210,362	127,861	76,552	60,484	72,857
Last Close Price	9970.00	8607.65	5310.51	3228.09	2525.57	2976.40
PE Ratio	215.62	185.90	82.35	81.76	103.71	80.66
PS Ratio	14.54	12.54	10.27	8.09	7.93	9.25
PB Ratio	32.40	27.93	18.68	13.79	12.49	16.50
P/TBV Ratio	32.42	27.95	18.74	13.79	12.49	16.50
P/FCF Ratio	392.33	338.25	777.38	163.12	70.07	77.53
P/OCF Ratio	381.82	329.19	477.25	139.27	63.38	71.82
EV/Sales Ratio	14.25	12.26	9.87	7.63	7.51	8.96
EV/EBITDA Ratio	96.29	82.83	69.81	47.45	73.16	54.94
EV/EBIT Ratio	114.29	98.31	74.58	51.43	87.20	62.67
EV/FCF Ratio	384.45	330.71	747.29	153.81	66.33	75.06
Debt / Equity Ratio	0.05	0.05	0.01	0.01	0.02	0.03
Debt / EBITDA Ratio	0.14	0.14	0.02	0.04	0.10	0.09
Debt / FCF Ratio	0.56	0.56	0.27	0.14	0.10	0.13
Asset Turnover	1.32	1.32	1.26	1.09	0.99	1.10
Inventory Turnover	2.48	2.48	2.87	2.22	2.11	1.85
Quick Ratio	1.03	1.03	1.89	1.61	1.64	1.46
Current Ratio	1.91	1.91	2.61	2.18	2.12	2.04
Return on Equity (ROE)	15.62%	15.62%	24.84%	18.05%	12.73%	22.74%
Return on Assets (ROA)	10.30%	10.30%	10.39%	10.11%	5.32%	9.81%
Return on Capital (ROIC)	17.57%	17.57%	16.33%	16.67%	8.77%	17.21%
Return on Capital Employed (ROCE)	26.30%	26.30%	23.80%	24.80%	13.20%	24.70%
Earnings Yield	0.46%	0.54%	1.21%	1.22%	0.96%	1.24%
FCF Yield	0.25%	0.30%	0.13%	0.61%	1.43%	1.29%
Dividend Yield	0.24%	0.37%	0.45%	0.50%	0.40%	0.07%
Payout Ratio	51.84%	51.84%	24.77%	20.14%	8.12%	5.36%
Buyback Yield / Dilution	0.01%	0.01%	-	-	-	-
Total Shareholder Return	0.25%	0.38%	0.45%	0.50%	0.40%	0.07%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.